AUBN
Auburn National Bancorporation, Inc.
There isn't enough reported data to score AUBN yet.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
AUBN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
AUBN's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like AUBN.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
AUBN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $25.91 | -0.1% |
| Current | 10x | $25.93 | — |
| Fair | 14x | $34.22 | +32% |
| Expensive | 21x | $53.36 | +106% |
Historical ranges are pointers, not guarantees.
AUBN's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
AUBN Forward outlook
There aren't enough analyst estimates for AUBN to show an outlook.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
AUBN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.49 | +21% |
| Q2 2026 | $2.41 | +26% |
| Q1 2026 | $2.27 | +20% |
| Q4 2025 | $2.08 | +13% |
| Q3 2025 | $2.05 | +720% |
| Q2 2025 | $1.91 | +961% |
| Q1 2025 | $1.89 | +722% |
| Q4 2024 | $1.84 | +360% |
AUBN has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
AUBN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $9M | +7% |
| Q2 2026 | $8.8M | +7.8% |
| Q1 2026 | $8.6M | +11% |
| Q4 2025 | $8.5M | +8.4% |
| Q3 2025 | $8.4M | +10% |
| Q2 2025 | $8.1M | +6.9% |
| Q1 2025 | $7.8M | +3.3% |
| Q4 2024 | $7.8M | +1140% |
AUBN's revenue has grown year over year for nine quarters in a row: $9M last quarter, up 7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 35% | +1.1 points |
| Q2 2026 | 33% | +4.7 points |
| Q1 2026 | 32% | +7.8 points |
| Q4 2025 | 25% | -5.5 points |
| Q3 2025 | 34% | +4.3 points |
| Q2 2025 | 29% | -0.6 points |
| Q1 2025 | 25% | +4.3 points |
| Q4 2024 | 31% | +904 points |
AUBN has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
AUBN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $1.5M | -29% |
| Q1 2026 | $2.5M | -3.5% |
| Q3 2025 | $4.1M | +117% |
| Q2 2025 | $2.1M | -30% |
| Q1 2025 | $2.6M | -15% |
| Q3 2024 | $1.9M | -43% |
| Q2 2024 | $3M | +23% |
| Q1 2024 | $3.1M | -37% |
AUBN has the stronger cash trend. Its trailing FCF is down 9.6% versus its history, compared with IREN at down 479%.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
AUBN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -6.9K shares |
| 1 year | -0.3% | -10.8K shares |
| 3 years | -0.3% | -11.2K shares |
| 5 years | -1.2% | -42.4K shares |
| Available history | -3% | -108K shares |
AUBN has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $195,000 |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | $130,000 |
| Q2 2023 | $35,000 |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
AUBN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -2.0x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -1.7x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -1.5x | Net Cash |
AUBN has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like AUBN.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
AUBN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.5 | Neutral |
| Stochastic | 53.4 | Neutral |
AUBN's weekly RSI is 49 (neutral) and its Stochastic is 53 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
AUBN PE vs Financial Services Sector
| Metric | AUBN | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 20% below |
| PE % | 17 | 63 | 46 pts below |
AUBN is trading at 10x earnings, a 20% discount to the Financial Services sector's median of 13x, though its earnings don't support one.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
AUBN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.4 | 1.9% below |
| 20 week MA | $26.6 | 2.5% below |
| 50 week MA | $25.5 | 1.6% above |
| 100 week MA | $24.5 | 5.9% above |
| 200 week MA | $22.7 | 14% above |
AUBN has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
AUBN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $53.8 | $42.6 | -21% |
| 2021 | $42.6 | $32.1 | -24% |
| 2022 | $32.1 | $23.3 | -27% |
| 2023 | $23.3 | $21.3 | -8.7% |
| 2024 | $21.3 | $23.9 | +12% |
| 2025 | $23.9 | $27.0 | +13% |
| 2026 YTD | $27.0 | $25.9 | -3.8% |
AUBN has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.